摘要
胃肝样腺癌是一种特殊类型的胃癌,具有发病率低、恶性度高、转移早、预后差等特点.由于病因及发病机制尚不清楚,临床表现与一般消化道肿瘤症状相似,因而易误诊;血清甲胎蛋白及癌胚抗原对该病诊断有辅助作用,组织病理学检查是诊断此病的金标准;目前治疗上以根治性手术联合化疗、介入治疗及生物免疫治疗等综合治疗为主.
Hepatoid adenocarcinoma of the stomach （HAS） is defined as a special type of gastric cancer characterized by low incidence rates and high degree of malignance with an extremely poor prognosis.As it is characterized by morphological similarities to general alimentary cannal symptoms with unclear etiology and pathogenesis,diagnostic errors can always be made.The alpha-fetoprotein （AFP） and carcino-embryonic antigen （CEA） are helpful with diagnosis.However,histopathological examination is the gold standard for diagnosing HAS.So far,radical operation,adjuvant chemotherapy,interventional therapy with immune-biological treatment are the main approaches for HAS treatment.
出处
《国际外科学杂志》
2015年第4期265-269,共5页
International Journal of Surgery
关键词
胃肿瘤
腺癌
组织病理
诊断
Stomach neoplasms
Adenocacinoma
Histopathology
Diagnosis
